GANX · Gain Therapeutics, Inc.
$1.83
-0.08 (-3.94%)
At close · Aug 26
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our projected cash outflows for the upcoming periods raise substantial doubt about our ability to continue as a going concern for at least 12 months from the issuance of the financial statements included elsewhere in this Quarterly Report.”View the 10-Q filed Aug 11, 2026
Market Cap
$83.14M
Shares
43.64M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-07-16 | — | |
| 8-K | 2026-06-29 | — | |
| 8-K | 2026-06-25 | 2026-06-24 | |
| 8-K | 2026-05-26 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-05-11 | — | |
| DEF 14A | 2026-04-28 | 2026-06-24 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-03-26 | — | |
| 8-K | 2026-03-18 | — | |
| 8-K | 2026-02-03 | — | |
| 8-K | 2025-12-18 | — | |
| 8-K | 2025-11-28 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-10-14 | — | |
| 8-K | 2025-10-09 | 2025-10-06 | |
| 8-K | 2025-10-06 | — | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-07-17 | 2025-07-15 | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-06-24 | — | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| DEF 14A | 2025-04-29 | 2025-06-24 | |
| 8-K | 2025-04-10 | — | |
| 10-K | 2025-03-27 | 2024-12-31 | |
| 8-K | 2025-03-27 | — | |
| 8-K | 2025-02-06 | — | |
| 8-K | 2025-01-15 | 2025-01-08 | |
| 8-K | 2025-01-07 | 2025-01-06 | |
| 8-K | 2024-12-23 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-14 | — | |
| 8-K | 2024-10-21 | — | |
| 8-K | 2024-10-08 | 2024-10-07 | |
| 8-K | 2024-09-06 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-07-12 | 2024-07-11 | |
| 8-K | 2024-07-09 | — | |
| 8-K | 2024-06-28 | 2024-06-25 | |
| 8-K | 2024-06-25 | 2024-06-24 | |
| 8-K | 2024-06-14 | 2024-06-13 | |
| 8-K | 2024-05-14 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 |
Showing 1–50 of 93 filings
Key facts
CIK
1819411
CUSIP
36269B105
13F (30d)
45 filings
45 filers
Visit website
Investor relations